摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-nitro-4-oxo-chroman-2-yl-acetic acid (ethyl ester) | 377091-05-9

中文名称
——
中文别名
——
英文名称
6-nitro-4-oxo-chroman-2-yl-acetic acid (ethyl ester)
英文别名
ethyl 2-(6-nitro-4-oxo-chroman-2-yl) acetate;Ethyl 2-(6-nitro-4-oxo-2,3-dihydrochromen-2-yl)acetate
6-nitro-4-oxo-chroman-2-yl-acetic acid (ethyl ester)化学式
CAS
377091-05-9
化学式
C13H13NO6
mdl
——
分子量
279.249
InChiKey
PEFIGPAWGZPMNB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    20
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    98.4
  • 氢给体数:
    0
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    ethyl 2-(4-oxo-3,4-dihydro-2H-chromen-2-yl)acetate 以80%的产率得到6-nitro-4-oxo-chroman-2-yl-acetic acid (ethyl ester)
    参考文献:
    名称:
    Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
    摘要:
    揭示了生产富含至少一种(2R或2S)对映体的香豆素组合物的工艺步骤和新型工艺,优选为香豆素-2-基羧酸化合物和香豆素-2-基羧酸酯,它们是生产血小板聚集抑制剂的中间体和/或本身是有效的血小板聚集抑制剂。进一步揭示了用于解析手性中间体或最终产品以提供所需对映体的酶促过程。
    公开号:
    US20040053992A1
点击查看最新优质反应信息

文献信息

  • Chiral and achiral synthesis of 2-acyl substituted chromanes and their derivatives
    申请人:——
    公开号:US20040044225A1
    公开(公告)日:2004-03-04
    Disclosed are processes for producing a (2S) or (2R) 4-oxo-chroman-2-yl acyl compounds and chroman-2-yl acyl compounds, esters or amides thereof as well as derivatives thereof. Such processes may involve chiral synthesis or achiral synthesis, preferably coupled with a resolution procedure. Such compounds, particularly (2S) or (2R) acetic acid esters, are useful intermedates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are processes for making derivatives of such substantially pure, or enhanced compositions of single (2R) or (2S) enantiomer intermediates or processes for producing final products or salts from such desired enantiomers.
    本发明涉及制备(2S)或(2R)4-氧代-2-基香豆素酰基化合物和香豆素酰基化合物、酯或酰胺以及它们的衍生物的方法。这些方法可以涉及手性合成或非手性合成,优选与分离程序相结合。这些化合物,特别是(2S)或(2R)乙酸酯,可用作生产血小板聚集抑制剂的中间体,或者它们本身就是强效的血小板聚集抑制剂。本发明还涉及制备这些纯度高的单一(2R)或(2S)对映体中间体的衍生物的方法,或者从这些所需对映体制备最终产品或盐的方法。
  • METHODS FOR PRODUCING CHIRAL CHROMONES, CHROMANES, AMINO SUBSTITUTED CHROMANES AND INTERMEDIATES THEREFOR
    申请人:MILLENIUM PHARMACEUTICALS, INC.
    公开号:EP1292589A2
    公开(公告)日:2003-03-19
  • US6756403B2
    申请人:——
    公开号:US6756403B2
    公开(公告)日:2004-06-29
  • [EN] CHIRAL AND ACHIRAL SYNTHESIS OF 2-ACYL SUBSTITUTED CHROMANES AND THEIR DERIVATIVES<br/>[FR] SYNTHESE CHIRALE ET ACHIRALE DE CHROMANES SUBSTITUES PAR 2-ACYLE ET LEURS DERIVES
    申请人:COR THERAPEUTICS INC
    公开号:WO2001092249A2
    公开(公告)日:2001-12-06
    Disclosed are processes for producing a (2S) or (2R) 4-oxo-chroman-2-yl acyl compounds and chroman-2-yl acyl compounds, esters or amides thereof as well as derivatives thereof. Such processes may involve chiral synthesis or achiral synthesis, preferably coupled with a resolution procedure. Such compounds, particularly (2S) or (2R) acetic acid esters, are useful intermediates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are processes for making derivatives of such substantially pure, or enhanced compositions of single (2R) or (2S) enantiomer intermediates or processes for producing final products or salts from such desired enantiomers.
  • [EN] METHODS FOR PRODUCING CHIRAL CHROMONES, CHROMANES, AMINO SUBSTITUTED CHROMANES AND INTERMEDIATES THEREFOR<br/>[FR] PROCEDES DE PRODUCTION DE CHROMONES CHIRAUX, DE CHROMANES, ET DE CHROMANES AMINO SUBSTITUES ET LEURS INTERMEDIAIRES
    申请人:LILLY CO ELI
    公开号:WO2001094335A2
    公开(公告)日:2001-12-13
    Disclosed are process steps and novel processes for producing chromane compositions enriched in at least one (2R or 2S) enantiomer, preferably chroman-2-yl carboxylic acid compounds and chroman-2-yl carboxylic acid esters which are intermediates for producing platelet aggregation inhibitors and/or are themselves potent platelet aggregation inhibitors. Further disclosed are enzymatic processes for resolving chiral intermediates or final products to provide desired enantiomers.
查看更多